VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 210 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $286 | +5.9% | 11,678 | +0.6% | 0.04% | 0.0% |
| Q1 2023 | $270 | -9.4% | 11,605 | -1.3% | 0.04% | -81.1% |
| Q4 2022 | $298 | -99.9% | 11,755 | -2.9% | 0.20% | +59.3% |
| Q3 2022 | $233,000 | -29.0% | 12,105 | -5.9% | 0.12% | -26.8% |
| Q2 2022 | $328,000 | -53.9% | 12,870 | -24.3% | 0.17% | +97.6% |
| Q4 2021 | $712,000 | -14.4% | 17,001 | -11.0% | 0.08% | -29.2% |
| Q3 2021 | $832,000 | -12.6% | 19,111 | -5.1% | 0.12% | -14.9% |
| Q2 2021 | $952,000 | -5.9% | 20,131 | +2.0% | 0.14% | -22.5% |
| Q1 2021 | $1,012,000 | – | 19,744 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $40,100,000 | 21.56% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,216,644 | $571,412,000 | 2.71% |
| Nan Fung Group Holdings Ltd | 210,563 | $5,416,000 | 2.57% |
| Taikang Asset Management (Hong Kong) Co Ltd | 533,332 | $13,717,000 | 2.34% |
| Crawford Lake Capital Management, LLC | 168,200 | $4,326,000 | 1.80% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 126,900 | $3,264,000 | 1.75% |
| Zebra Capital Management LLC | 22,227 | $572,000 | 1.31% |
| Alaska Permanent Fund Corp | 2,300,000 | $59,156,000 | 0.98% |
| CLARK ESTATES INC/NY | 180,000 | $4,630,000 | 0.73% |
| Temasek Holdings (Private) Ltd | 5,602,553 | $144,097,663 | 0.61% |